Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hypersensitivity Reaction

  Free Subscription


Articles published in J Am Acad Dermatol

Retrieve available abstracts of 275 articles:
HTML format



Single Articles


    July 2021
  1. EDIGIN E, Kichloo A, El-Amir Z, Wani F, et al
    National Trends in Hospitalizations of Atopic Dermatitis Adult Patients: A 21-Year Longitudinal United States Population Based Study.
    J Am Acad Dermatol. 2021 Jul 9. pii: S0190-9622(21)02084.
    PubMed    


  2. PARK SK, Kim JS, Seo HM
    Exposure to air pollution and incidence of atopic dermatitis in the general population: A national population-based retrospective cohort study.
    J Am Acad Dermatol. 2021 Jul 6. pii: S0190-9622(21)02066.
    PubMed     Abstract available


  3. MCMAHON DE, Amerson E, Rosenbach M, Lipoff JB, et al
    Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.
    J Am Acad Dermatol. 2021;85:46-55.
    PubMed     Abstract available


    June 2021
  4. RICK JW, Alavi A, Hsiao JL, Yosipovitch G, et al
    Atopic Dermatitis and Hidradenitis Suppurativa: An Under-recognized Pair.
    J Am Acad Dermatol. 2021 Jun 29. pii: S0190-9622(21)01995.
    PubMed    


  5. WILLIAMS HC
    New topical treatments for atopic dermatitis - active comparators are needed.
    J Am Acad Dermatol. 2021 Jun 18. pii: S0190-9622(21)01098.
    PubMed    


  6. NARLA S, Silverberg JI, Simpson EL
    Management of inadequate response and adverse effects to dupilumab in atopic dermatitis.
    J Am Acad Dermatol. 2021 Jun 11. pii: S0190-9622(21)01119.
    PubMed     Abstract available


  7. NAKAGAWA H, Nemoto O, Igarashi A, Saeki H, et al
    Delgocitinib ointment in pediatric patients with atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study.
    J Am Acad Dermatol. 2021 Jun 9. pii: S0190-9622(21)01116.
    PubMed     Abstract available


    May 2021
  8. SCHWARTZ BL, Honari G, Chiou AS, Ko J, et al
    Prevalence of Potentially Allergenic Ingredients in Products Labeled for Eczema Care.
    J Am Acad Dermatol. 2021 May 28. pii: S0190-9622(21)01030.
    PubMed    


  9. SHERMAN S, Bitan DT, Leshem YA, Hodak E, et al
    Reply to: Comments on "Hidradenitis Suppurativa and Atopic Dermatitis: A Two-Way Association".
    J Am Acad Dermatol. 2021 May 24. pii: S0190-9622(21)01004.
    PubMed    


  10. PAPP K, Szepietowski JC, Kircik L, Toth D, et al
    Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies.
    J Am Acad Dermatol. 2021 May 3. pii: S0190-9622(21)00931.
    PubMed     Abstract available


    April 2021
  11. GAO DX, Kahn JS, Cohen SR, Fiumara K, et al
    Treatment of patients with atopic dermatitis with weekly dupilumab dosing: a single institutional retrospective medical record review and survey.
    J Am Acad Dermatol. 2021 Apr 21. pii: S0190-9622(21)00883.
    PubMed    


  12. HONG MR, Lei D, Yousaf M, Chavda R, et al
    A real-world study of the longitudinal course of skin-pain in adult atopic dermatitis.
    J Am Acad Dermatol. 2021 Apr 16. pii: S0190-9622(21)00820.
    PubMed    


  13. WOHLTMANN W
    JAAD Game Changers: Sleep disturbance in children with moderate/severe atopic dermatitis: A case-control study.
    J Am Acad Dermatol. 2021 Apr 11. pii: S0190-9622(21)00757.
    PubMed    


    March 2021
  14. MEROLA JF, Bagel J, Almgren P, Ropke M, et al
    Tralokinumab Does Not Impact Vaccine-induced Immune Responses: Results From a 30-week, Randomized, Placebo-controlled Trial in Adults With Moderate-to-severe Atopic Dermatitis.
    J Am Acad Dermatol. 2021 Mar 17. pii: S0190-9622(21)00577.
    PubMed     Abstract available


  15. HUANG AH, Roh YS, Sutaria N, Choi J, et al
    Real-world comorbidities of atopic dermatitis in the pediatric ambulatory population in the United States.
    J Am Acad Dermatol. 2021 Mar 6. pii: S0190-9622(21)00507.
    PubMed     Abstract available


  16. BOSMA AL, de Wijs LEM, Hof MH, van Nieuwenhuizen BR, et al
    Reply to "Comment on 'Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry'".
    J Am Acad Dermatol. 2021 Mar 3. pii: S0190-9622(21)00469.
    PubMed    


  17. CHENG BT, Silverberg JI
    Association of pediatric atopic dermatitis and psoriasis with school absenteeism and parental work absenteeism: a cross-sectional United States population-based study.
    J Am Acad Dermatol. 2021 Mar 2. pii: S0190-9622(21)00465.
    PubMed     Abstract available


  18. SEO HM, Oh SU, Park SK, Kim JS, et al
    Comment on "Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry".
    J Am Acad Dermatol. 2021 Mar 2. pii: S0190-9622(21)00468.
    PubMed    


    February 2021
  19. COTTON C
    JAAD Game Changers: Sleep disturbance in children with moderate/severe atopic dermatitis: A case-control study.
    J Am Acad Dermatol. 2021 Feb 25. pii: S0190-9622(21)00342.
    PubMed    


  20. JO CE, Mufti A, Sachdeva M, Pratt M, et al
    Effect of dupilumab on allergic contact dermatitis and patch testing.
    J Am Acad Dermatol. 2021 Feb 19. pii: S0190-9622(21)00403.
    PubMed    


  21. SIMPSON EL, Forman S, Silverberg JI, Zirwas M, et al
    Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy Phase 3 trial in the United States and Canada (BREEZE-AD5).
    J Am Acad Dermatol. 2021 Feb 15. pii: S0190-9622(21)00353.
    PubMed     Abstract available


    January 2021
  22. MCKENZIE PL, Castelo-Soccio L
    Dupilumab Therapy for Alopecia Areata in Pediatric Patients with Concomitant Atopic Dermatitis.
    J Am Acad Dermatol. 2021 Jan 20. pii: S0190-9622(21)00195.
    PubMed    


  23. SCHWARTZMAN G, Lei D, Yousaf M, Janmohamed SR, et al
    Validity and reliability of Patient-Reported Outcomes Measurement Information System Global Health scale in adults with atopic dermatitis.
    J Am Acad Dermatol. 2021 Jan 20. pii: S0190-9622(21)00180.
    PubMed     Abstract available


  24. SMIESZEK SP, Przychodzen B, Welsh SE, Brzezynski JL, et al
    Genomic and phenotypic characterization of Investigator Global Assessment (IGA) scale based endotypes in atopic dermatitis.
    J Am Acad Dermatol. 2021 Jan 6. pii: S0190-9622(21)00005.
    PubMed    


  25. LEWINSON RT, Meyers DE, Vallerand IA, Suo A, et al
    Machine learning for prediction of cutaneous adverse events in patients receiving anti-PD-1 immunotherapy.
    J Am Acad Dermatol. 2021;84:183-185.
    PubMed    


  26. HALLING AS, Loft N, Silverberg JI, Guttman-Yassky E, et al
    Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2021;84:139-147.
    PubMed     Abstract available


  27. MARZANO AV, Genovese G, Tavecchio S, Germiniasi F, et al
    Clinical and immunopathologic features of idiopathic cutaneous immunoglobulin M/G vasculitis versus idiopathic skin-limited immunoglobulin A vasculitis.
    J Am Acad Dermatol. 2021;84:175-178.
    PubMed    


    December 2020
  28. SHERMAN S, Kridin K, Bitan DT, Leshem YA, et al
    Hidradenitis Suppurativa and Atopic Dermatitis: A Two-Way Association.
    J Am Acad Dermatol. 2020 Dec 27. pii: S0190-9622(20)33250.
    PubMed     Abstract available


  29. ALI Z, Andersen AD, Bjerre-Christensen T, Zibert JR, et al
    Agreement between dermatologists' selection of the lesional area and characteristics best representing atopic dermatitis severity: online survey.
    J Am Acad Dermatol. 2020 Dec 22. pii: S0190-9622(20)33236.
    PubMed    


  30. DRAELOS ZD, Ports WC, Vlahos B, Yeoh T, et al
    Skin permeation and penetration of crisaborole when coapplied with emollients.
    J Am Acad Dermatol. 2020;83:1801-1803.
    PubMed    


    November 2020
  31. RAVN NH, Ahmadzay ZF, Christensen TA, Larsen HHP, et al
    Bidirectional Association between Atopic Dermatitis, Conjunctivitis and other Ocular Surface Diseases: A Systemic Review and Meta-Analysis.
    J Am Acad Dermatol. 2020 Nov 27. pii: S0190-9622(20)33077.
    PubMed     Abstract available


  32. NEALE H, Garza-Mayers AC, Tam I, Yu J, et al
    Pediatric Allergic Contact Dermatitis. Part II. Patch Testing Series, Procedure, and Unique Scenarios.
    J Am Acad Dermatol. 2020 Nov 17. pii: S0190-9622(20)32909.
    PubMed     Abstract available


  33. NEALE H, Garza-Mayers AC, Tam I, Yu J, et al
    Pediatric Allergic Contact Dermatitis. Part I. Clinical Features and Common Contact Allergens in Children.
    J Am Acad Dermatol. 2020 Nov 17. pii: S0190-9622(20)32910.
    PubMed     Abstract available


  34. PATHANIA YS, Budania A
    Comment on "Children with chronic urticaria can be effectively controlled with updosing second-generation antihistamines".
    J Am Acad Dermatol. 2020;83:e363-e364.
    PubMed    


  35. GABRIELLI S, Le M, Netchiporouk E, Miedzybrodzki B, et al
    Reply to "Comment on: 'Children with chronic urticaria can be effectively controlled with updosing second-generation antihistamines'".
    J Am Acad Dermatol. 2020;83:e365-e366.
    PubMed    


  36. LIPNER SR, Wang Y
    Retrospective analysis of dermatologic adverse events associated with hydroxychloroquine reported to the US Food and Drug Administration.
    J Am Acad Dermatol. 2020;83:1527-1529.
    PubMed    


  37. MUZUMDAR S, Zubkov M, Waldman R, DeWane ME, et al
    Characterizing dupilumab facial redness in children and adolescents: A single-institution retrospective chart review.
    J Am Acad Dermatol. 2020;83:1520-1521.
    PubMed    


  38. HOFFMAN KP, Chung C, Parikh S, Kwatra SG, et al
    Immunoglobulin A expression in adult cutaneous leukocytoclastic vasculitis and its effect on hospital outcomes.
    J Am Acad Dermatol. 2020;83:1511-1513.
    PubMed    


  39. GEISLER AN, Phillips GS, Barrios DM, Wu J, et al
    Immune checkpoint inhibitor-related dermatologic adverse events.
    J Am Acad Dermatol. 2020;83:1255-1268.
    PubMed     Abstract available


  40. SIMONSEN AB, Kaae J, Ellebaek E, Svane IM, et al
    Cutaneous adverse reactions to anti-PD-1 treatment-A systematic review.
    J Am Acad Dermatol. 2020;83:1415-1424.
    PubMed     Abstract available


  41. KIM GY, Anderson KR, Davis DMR, Hand JL, et al
    Drug reaction with eosinophilia and systemic symptoms (DRESS) in the pediatric population: A systematic review of the literature.
    J Am Acad Dermatol. 2020;83:1323-1330.
    PubMed     Abstract available


  42. MOLINA GE, Yu Z, Foreman RK, Reynolds KL, et al
    Generalized bullous mucocutaneous eruption mimicking Stevens-Johnson syndrome in the setting of immune checkpoint inhibition: A multicenter case series.
    J Am Acad Dermatol. 2020;83:1475-1477.
    PubMed    


  43. PETTY AJ, Cardones AR, Marano AL
    Analysis of clinical characteristics of drug-induced cutaneous lupus erythematosus in men.
    J Am Acad Dermatol. 2020;83:1455-1457.
    PubMed    


    October 2020
  44. SCHNEEWEISS MC, Kim SC, Wyss R, Schneeweiss S, et al
    Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: a propensity score-matched cohort study.
    J Am Acad Dermatol. 2020 Oct 7. pii: S0190-9622(20)32685.
    PubMed     Abstract available


  45. ELLIS SR, Vierra AT, Millsop JW, Lacouture ME, et al
    Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features.
    J Am Acad Dermatol. 2020;83:1130-1143.
    PubMed     Abstract available


  46. LOWE AJ, Lee B, Orchard D, King E, et al
    Palm reading and water divining: A cross-sectional study of the accuracy of palmar hyperlinearity and transepidermal water loss to identify individuals with a filaggrin gene null mutation.
    J Am Acad Dermatol. 2020;83:1186-1188.
    PubMed    


  47. CUNNINGHAM L, Menzies S, Moore E, Shudell E, et al
    Mucocutaneous adverse effects of the genital and perianal skin from isotretinoin therapy.
    J Am Acad Dermatol. 2020;83:1174-1175.
    PubMed    


  48. LEE H, Jung SJ, Patel AB, Thompson JM, et al
    Racial characteristics of alopecia areata in the United States.
    J Am Acad Dermatol. 2020;83:1064-1070.
    PubMed     Abstract available


    September 2020
  49. VAN DER KOLK TN, Buters TP, Krouwels L, Boltjes J, et al
    Topical anti-microbial peptide omiganan recovers cutaneous dysbiosis but does not improve clinical symptoms in patients with mild-to-moderate atopic dermatitis in a phase 2 randomized controlled trial.
    J Am Acad Dermatol. 2020 Sep 30. pii: S0190-9622(20)32659.
    PubMed     Abstract available


  50. CHENG J, Jiang L, Morrow NC, Avdic A, et al
    Recognition of Atopic Keratoconjunctivitis During Treatment with Dupilumab for Atopic Dermatitis.
    J Am Acad Dermatol. 2020 Sep 18. pii: S0190-9622(20)32636.
    PubMed    


  51. RUGE IF, Thorsteinsdottir S, Norgaard S, Chawes BL, et al
    Symptom burden of atopic dermatitis in early childhood assessed from daily monitoring of symptoms and topical steroid usage.
    J Am Acad Dermatol. 2020 Sep 17. pii: S0190-9622(20)32626.
    PubMed     Abstract available


  52. ARIENS LF, van der Schaft J, Spekhorst LS, Bakker DS, et al
    Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-weeks results from the Dutch BioDay registry.
    J Am Acad Dermatol. 2020 Sep 15. pii: S0190-9622(20)32618.
    PubMed     Abstract available


  53. CHO YT, Yang CW, Chen YC, Chu CY, et al
    Comment on "Viral reactivation in hospitalized DRESS patients: A retrospective study from a tertiary medical center in the United States".
    J Am Acad Dermatol. 2020;83:e209-e210.
    PubMed    


  54. MILANI-NEJAD N, Trinidad J, Kaffenberger BH
    Reply to: "Comment on Viral reactivation in hospitalized DRESS patients: A retrospective study from a tertiary medical center in the United States".
    J Am Acad Dermatol. 2020;83:e211.
    PubMed    


    August 2020
  55. SCHELL SL, Sun H, Maczuga S, Kirby JS, et al
    Cross-sectional study reveals reduced odds of allergies in people with hidradenitis suppurativa.
    J Am Acad Dermatol. 2020 Aug 8. pii: S0190-9622(20)32369.
    PubMed    


  56. MARTINEZ-LOPEZ A, Cuenca-Barrales C, Montero-Vilchez T, Molina-Leyva A, et al
    Review of adverse cutaneous reactions of pharmacologic interventions for coronavirus disease 2019 (COVID-19): a guide for the dermatologist.
    J Am Acad Dermatol. 2020 Aug 7. pii: S0190-9622(20)32358.
    PubMed     Abstract available


  57. NADA HR, Rashed LA, Mohamed AM, Abdelkader HA, et al
    Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in psoriasis and atopic dermatitis: a case control study.
    J Am Acad Dermatol. 2020 Aug 6. pii: S0190-9622(20)32354.
    PubMed    


  58. DROITCOURT C, Vittrup I, Kerbrat S, Egeberg A, et al
    Risk of systemic infections in adults with atopic dermatitis: a nationwide cohort study.
    J Am Acad Dermatol. 2020 Aug 1. pii: S0190-9622(20)32314.
    PubMed     Abstract available


  59. HEYMANN WR
    Topical tacrolimus and malignancy risk: Should the theory be put to rest?
    J Am Acad Dermatol. 2020;83:367-368.
    PubMed    


  60. SHARMA AN, Mesinkovska NA, Paravar T
    Characterizing the adverse dermatologic effects of hydroxychloroquine: A systematic review.
    J Am Acad Dermatol. 2020;83:563-578.
    PubMed     Abstract available


  61. HU S, Shangraw S, Newman S
    Assessing practice gaps in the outpatient management of cutaneous small vessel vasculitis.
    J Am Acad Dermatol. 2020;83:657-659.
    PubMed    


  62. BRAY JK, Johnson MC, Masicampo EJ, Feldman SR, et al
    Optimizing presentation of expected treatment outcomes.
    J Am Acad Dermatol. 2020;83:602-604.
    PubMed    


    July 2020
  63. MORRA DE, Cho E, Li T, Camargo CA Jr, et al
    Smoking and risk of adult-onset atopic dermatitis in US women.
    J Am Acad Dermatol. 2020 Jul 22. pii: S0190-9622(20)32278.
    PubMed    


  64. SUCHONWANIT P, Leerunyakul K, Kositkuljorn C
    Cutaneous manifestations in COVID-19: Lessons learned from current evidence.
    J Am Acad Dermatol. 2020;83:e57-e60.
    PubMed    


  65. SASIDHARANPILLAI S, Ajithkumar K, Khader A, Reena Mariyath OK, et al
    Drug reaction with eosinophilia and systemic symptoms within 1 week of exposure to the drug.
    J Am Acad Dermatol. 2020;83:e17-e18.
    PubMed    


  66. MILANI-NEJAD N, Trinidad J, Kaffenberger BH
    Viral reactivation in hospitalized patients with drug reaction with eosinophilia and systemic symptoms: A retrospective study from a tertiary medical center in the United States.
    J Am Acad Dermatol. 2020;83:278-279.
    PubMed    


  67. ISOM J, Braswell DS, Siroy A, Auerbach J, et al
    Clinical and histopathologic features differentiating acute generalized exanthematous pustulosis and pustular psoriasis: A retrospective series.
    J Am Acad Dermatol. 2020;83:265-267.
    PubMed    


  68. YANES D, Nguyen E, Imadojemu S, Kroshinsky D, et al
    Cyclosporine for treatment of acute generalized exanthematous pustulosis: A retrospective analysis.
    J Am Acad Dermatol. 2020;83:263-265.
    PubMed    


    June 2020
  69. PALLER AS, Siegfried EC, Thaci D, Wollenberg A, et al
    Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial.
    J Am Acad Dermatol. 2020 Jun 20. pii: S0190-9622(20)31152.
    PubMed     Abstract available


  70. YEW YW, Dinish US, Yu Kuan AH, Li X, et al
    Raster-scanning optoacoustic mesoscopy (RSOM) imaging as an objective disease severity tool in atopic dermatitis patients.
    J Am Acad Dermatol. 2020 Jun 16. pii: S0190-9622(20)31142.
    PubMed    


  71. YOU J, Sun L, Zhao Q, Zhang H, et al
    Dynamic cytokine profiles combined with enzyme-linked immunospot assay are useful for immunologically confirming the dapsone hypersensitivity syndrome.
    J Am Acad Dermatol. 2020 Jun 15. pii: S0190-9622(20)31093.
    PubMed    


  72. KEARNS DG, Uppal S, Chat VS, Wu JJ, et al
    Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic.
    J Am Acad Dermatol. 2020 Jun 10. pii: S0190-9622(20)31075.
    PubMed    


  73. FISHBEIN AB, Lor J, Penedo FJ, Forrest CB, et al
    Patient-Reported Outcomes for Measuring Sleep Disturbance in Pediatric Atopic Dermatitis: cross sectional study of PROMIS Pediatric Sleep Measures and Actigraphy.
    J Am Acad Dermatol. 2020 Jun 3. pii: S0190-9622(20)31015.
    PubMed     Abstract available


  74. DE BRUIN-WELLER M, Simpson EL, Cork M, Chen Z, et al
    Dupilumab reduces absenteeism in patients with moderate-to-severe atopic dermatitis: pooled results from the LIBERTY AD SOLO clinical trials.
    J Am Acad Dermatol. 2020 Jun 3. pii: S0190-9622(20)31019.
    PubMed    


  75. PALLER AS, Gold LS, Soung J, Tallman AM, et al
    Efficacy and Patient-Reported Outcomes from a Phase IIb, Randomized Clinical Trial of Tapinarof Cream for the Treatment of Adolescents and Adults with Atopic Dermatitis.
    J Am Acad Dermatol. 2020 Jun 2. pii: S0190-9622(20)31011.
    PubMed     Abstract available


  76. PETERSON D, Damsky W, King B
    The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    J Am Acad Dermatol. 2020;82:e223-e226.
    PubMed    


  77. LERTPHANICHKUL C, Scheinman PL
    Occupational allergic contact dermatitis (OACD) in a cohort of 458 consecutive dermatitis patients; A case series of 17 patients with OACD.
    J Am Acad Dermatol. 2020 Jun 1. pii: S0190-9622(20)31008.
    PubMed    


  78. LEE H, Lee JH, Koh SJ, Park H, et al
    Bidirectional relationship between atopic dermatitis and inflammatory bowel disease: a systematic review and meta-analysis.
    J Am Acad Dermatol. 2020 Jun 1. pii: S0190-9622(20)31006.
    PubMed     Abstract available


  79. HEYMANN WR
    The renal reality of adult Henoch-Schonlein purpura.
    J Am Acad Dermatol. 2020;82:1303-1304.
    PubMed    


  80. JACOBSEN AA, Pearson DR
    The age of procalcitonin: potential pitfalls in critically ill patients with SJS/TEN. A comment on "Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cohort study of 176 patients".
    J Am Acad Dermatol. 2020;82:e247.
    PubMed    


  81. KOH HK, Lee HY
    Reply to: "The age of procalcitonin: Potential pitfalls in critically ill patients with SJS/TEN. A comment on 'Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cohort study of 176 patients
    J Am Acad Dermatol. 2020;82:e249.
    PubMed    


  82. SEMINARIO-VIDAL L, Kroshinsky D, Malachowski SJ, Sun J, et al
    Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults.
    J Am Acad Dermatol. 2020;82:1553-1567.
    PubMed     Abstract available


  83. JUSTO ADS, Lemes BM, Nunes B, Antunes KA, et al
    Depth of injury of Hetter's phenol-croton oil chemical peel formula using 2 different emulsifying agents.
    J Am Acad Dermatol. 2020;82:1544-1546.
    PubMed    


  84. SINGH P, Silverberg JI
    Adverse event monitoring in patients on oral systemic medications for inflammatory skin disease.
    J Am Acad Dermatol. 2020;82:1537-1539.
    PubMed    


  85. GABRIELLI S, Le M, Netchiporouk E, Miedzybrodzki B, et al
    Chronic urticaria in children can be controlled effectively with updosing second-generation antihistamines.
    J Am Acad Dermatol. 2020;82:1535-1537.
    PubMed    


  86. WANG CY, Zheng RRC, Doerrer ZA, Kurta AO, et al
    Health care regulation, the Food and Drug Administration (FDA), and access to medicine: Our experience with dupilumab for children.
    J Am Acad Dermatol. 2020;82:1568-1569.
    PubMed    


  87. BAUMRIN E, Azzawi S, St John J, Hoang MP, et al
    Prognostic implications of normal or minimal urinary findings on long-term renal impairment in adults with Henoch-Schonlein purpura.
    J Am Acad Dermatol. 2020;82:1393-1399.
    PubMed     Abstract available


    May 2020
  88. BOSMA AL, de Wijs LEM, Hof MH, van Nieuwenhuizen BR, et al
    Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.
    J Am Acad Dermatol. 2020 May 30. pii: S0190-9622(20)31004.
    PubMed     Abstract available


  89. UCHIDA H, Kamata M, Kato A, Mizukawa I, et al
    One-year real-world clinical effectiveness, safety and laboratory safety of dupilumab in Japanese adult patients with atopic dermatitis: A single-center retrospective study.
    J Am Acad Dermatol. 2020 May 29. pii: S0190-9622(20)30977.
    PubMed    


  90. TOPHAM C, Haynes D, Brazil M, Simpson E, et al
    Initial validation of the product of the signs global assessment and body surface area (SGAxBSA) in atopic dermatitis.
    J Am Acad Dermatol. 2020 May 23. pii: S0190-9622(20)30967.
    PubMed     Abstract available


  91. KIM J, Kim S, Lee YI, Kim J, et al
    Eosinophil cationic protein is a potential surrogate marker of allergic contact dermatitis: A single-center, retrospective study of 216 patients.
    J Am Acad Dermatol. 2020 May 19. pii: S0190-9622(20)30938.
    PubMed    


  92. HIMADRI MD, George R, Mathew L, Vanitha S, et al
    The role of thymus and activation-regulated chemokine as a marker of severity of atopic dermatitis.
    J Am Acad Dermatol. 2020 May 18. pii: S0190-9622(20)30917.
    PubMed    


  93. SILVERBERG JI, Lei D, Yousaf M, Janmohamed SR, et al
    Association of atopic dermatitis severity with cognitive function in adults.
    J Am Acad Dermatol. 2020 May 16. pii: S0190-9622(20)30905.
    PubMed     Abstract available


  94. SHAH P, Milam EC, Lo Sicco KI, Cohen DE, et al
    Dupilumab for Allergic Contact Dermatitis (ACD) and Implications for Patch Testing: Irreconcilable Differences.
    J Am Acad Dermatol. 2020 May 14. pii: S0190-9622(20)30867.
    PubMed    


  95. SHAH M, Sachdeva M, Alavi A, Shi VY, et al
    Optimizing Care for Atopic Dermatitis Patients During COVID-19 Pandemic.
    J Am Acad Dermatol. 2020 May 13. pii: S0190-9622(20)30858.
    PubMed    


  96. CHEUNG K, Powers EM, McKillip J, Powers JG, et al
    Effect of statin use on incidence of eczema and atopic dermatitis: a retrospective cohort study.
    J Am Acad Dermatol. 2020 May 11. pii: S0190-9622(20)30843.
    PubMed    


  97. MEROLA JF, Sidbury R, Wollenberg A, Chen Z, et al
    Dupilumab prevents flares in adults with moderate-to-severe atopic dermatitis in a 52-week randomized controlled phase 3 trial.
    J Am Acad Dermatol. 2020 May 6. pii: S0190-9622(20)30822.
    PubMed    


  98. MOLINA GE, Yanovsky RL, Wei EX, Chen ST, et al
    Missed drug-induced bullous pemphigoid leads to longer immunosuppression than recognized cases: A 9-year retrospective review.
    J Am Acad Dermatol. 2020;82:1255-1258.
    PubMed    


  99. LESHEM YA, Chalmers JR, Apfelbacher C, Furue M, et al
    Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiative.
    J Am Acad Dermatol. 2020;82:1181-1186.
    PubMed     Abstract available


  100. COLLIS RW, Sheinbein DM
    Cocamidopropyl betaine is commonly found in hypoallergenic personal care products for children.
    J Am Acad Dermatol. 2020;82:1245-1247.
    PubMed    


    April 2020
  101. SIMPSON E, Bissonnette R, Eichenfield LF, Guttman E, et al
    The validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.
    J Am Acad Dermatol. 2020 Apr 25. pii: S0190-9622(20)30720.
    PubMed     Abstract available


  102. EZZEDINE K, Shourick J, Merhand S, Sampogna F, et al
    Perceived clinical severity of atopic dermatitis in adolescents: comparison between patients' and parents' evaluation.
    J Am Acad Dermatol. 2020 Apr 15. pii: S0190-9622(20)30618.
    PubMed    


  103. THERIANOU A, Vincenzi C, Tosti A
    How safe is prescribing oral minoxidil in patients allergic to topical minoxidil?
    J Am Acad Dermatol. 2020 Apr 11. pii: S0190-9622(20)30567.
    PubMed    


  104. PALLER AS, Folster-Holst R, Chen SC, Diepgen TL, et al
    No Evidence of Increased Cancer Incidence in Children Using Topical Tacrolimus for Atopic Dermatitis.
    J Am Acad Dermatol. 2020 Apr 1. pii: S0190-9622(20)30498.
    PubMed     Abstract available


  105. BASHYAM AM, Cuellar-Barboza A, Masicampo EJ, Feldman SR, et al
    Framing atopic dermatitis topical medication application site discomfort as a signal of efficacy improves willingness to continue use.
    J Am Acad Dermatol. 2020 Apr 1. pii: S0190-9622(20)30497.
    PubMed    


  106. KHOSRAVI H, Zhang S, Anderson AM, Ferris LK, et al
    Dupilumab drug survival, treatment failures, and insurance approval at a tertiary care center in the United States.
    J Am Acad Dermatol. 2020;82:1023-1024.
    PubMed    


  107. HEBERT AA, Siegfried EC, Durham T, de Leon EN, et al
    Efficacy and tolerability of an investigational nitric oxide-releasing topical gel in patients with molluscum contagiosum: A randomized clinical trial.
    J Am Acad Dermatol. 2020;82:887-894.
    PubMed     Abstract available


  108. HASAN ALI O, Bomze D, Ring SS, Berner F, et al
    BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors.
    J Am Acad Dermatol. 2020;82:854-861.
    PubMed     Abstract available


    March 2020
  109. PICCOLO V, Piraccini BM, Argenziano G, Russo T, et al
    Onychoscopy of allergic contact dermatitis due to artificial nails: a double-centre retrospective study on 35 patients.
    J Am Acad Dermatol. 2020 Mar 27. pii: S0190-9622(20)30468.
    PubMed    


  110. SILVERBERG JI, Yosipovitch G, Simpson EL, Kim BS, et al
    Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate-to-severe atopic dermatitis: analysis of the randomized phase 3 studies SOLO 1 & SOLO 2, AD ADOL, and CHRONOS.
    J Am Acad Dermatol. 2020 Mar 2. pii: S0190-9622(20)30305.
    PubMed     Abstract available


  111. WEINKLE A, Kaffenberger BH, Trinidad JC, Ergen EN, et al
    Reply to: "Response: Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation-A retrospective chart review".
    J Am Acad Dermatol. 2020;82:e113.
    PubMed    


  112. GEORGESEN C, Karim SA, Liu R, Moorhead A, et al
    Response: "Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation-A retrospective chart review".
    J Am Acad Dermatol. 2020;82:e111-e112.
    PubMed    


  113. HEYMANN WR
    The diagnostic criteria of DRESS syndrome must be addressed.
    J Am Acad Dermatol. 2020;82:573-574.
    PubMed    


  114. SORIA A, Bernier C, Veyrac G, Barbaud A, et al
    Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: A retrospective study.
    J Am Acad Dermatol. 2020;82:606-611.
    PubMed     Abstract available


  115. MOLINA GE, Allen IM, Hughes MS, Zubiri L, et al
    Prognostic implications of co-occurring dermatologic and gastrointestinal toxicity from immune checkpoint inhibition therapy for advanced malignancies: A retrospective cohort study.
    J Am Acad Dermatol. 2020;82:743-746.
    PubMed    


    February 2020
  116. RAVNBORG N, Ambikaibalan D, Agnihotri G, Price S, et al
    Prevalence of asthma in patients with atopic dermatitis: a systematic review and meta-analysis.
    J Am Acad Dermatol. 2020 Feb 26. pii: S0190-9622(20)30299.
    PubMed     Abstract available


  117. KIM EJ, Geskin L, Guitart J, Querfeld C, et al
    Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study.
    J Am Acad Dermatol. 2020 Feb 20. pii: S0190-9622(20)30057.
    PubMed    


  118. JO CE, Georgakopoulos JR, Ladda M, Ighani A, et al
    Evaluation of long-term efficacy, safety, and reasons for discontinuation of dupilumab for moderate-to-severe atopic dermatitis in clinical practice: A retrospective cohort study.
    J Am Acad Dermatol. 2020 Feb 16. pii: S0190-9622(20)30267.
    PubMed    


  119. KIM BS, Sun K, Papp K, Venturanza M, et al
    Effects of Ruxolitinib Cream on Pruritus and Quality of Life in Atopic Dermatitis: Results From a Phase 2, Randomized, Dose-Ranging, Vehicle- and Active-Controlled Study.
    J Am Acad Dermatol. 2020 Feb 11. pii: S0190-9622(20)30213.
    PubMed     Abstract available


  120. NAKAGAWA H, Nemoto O, Igarashi A, Saeki H, et al
    Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study.
    J Am Acad Dermatol. 2020 Feb 3. pii: S0190-9622(19)33289.
    PubMed     Abstract available


  121. BAGEL J, Lebwohl M, Israel RJ, Jacobson A, et al
    Immunogenicity and skin clearance recapture in clinical studies of brodalumab.
    J Am Acad Dermatol. 2020;82:344-351.
    PubMed     Abstract available


  122. COHEN JN, Bowman S, Laszik ZG, North JP, et al
    Clinicopathologic overlap of psoriasis, eczema, and psoriasiform dermatoses: A retrospective study of T helper type 2 and 17 subsets, interleukin 36, and beta-defensin 2 in spongiotic psoriasiform dermatitis, sebopsoriasis, and tumor necrosis factor a
    J Am Acad Dermatol. 2020;82:430-439.
    PubMed     Abstract available


    January 2020
  123. BASHYAM AM, Cuellar-Barboza A, Ghamrawi RI, Feldman SR, et al
    Placebo tailoring improves patient satisfaction of treatment plans in atopic dermatitis.
    J Am Acad Dermatol. 2020 Jan 28. pii: S0190-9622(20)30128.
    PubMed    


  124. MOUSTAFA D, Yu J
    Contact Allergy to Hydroperoxides of Limonene and Linalool in a Pediatric Population.
    J Am Acad Dermatol. 2020 Jan 28. pii: S0190-9622(20)30132.
    PubMed    


  125. SUH TP, Ramachandran D, Patel V, Jackson KL, et al
    Product of Investigator Global Assessment and body surface area (IGAxBSA): a practice-friendly alternative to the Eczema Area and Severity Index (EASI) to assess atopic dermatitis severity in children.
    J Am Acad Dermatol. 2020 Jan 20. pii: S0190-9622(20)30074.
    PubMed     Abstract available


  126. KAMRANI P, Nedorost S
    The value of pantomiming for allergic contact dermatitis.
    J Am Acad Dermatol. 2020 Jan 18. pii: S0190-9622(20)30078.
    PubMed    


  127. PRASAD S, Marks DH, Burns LJ, De Souza B, et al
    Patch testing and contact allergen avoidance in patients with lichen planopilaris and/or frontal fibrosing alopecia: a cohort study.
    J Am Acad Dermatol. 2020 Jan 18. pii: S0190-9622(20)30077.
    PubMed    


  128. LEDUCQ S, Samimi M, Bernier C, Soria A, et al
    Efficacy and safety of methotrexate versus placebo as add-on therapy to H1 antihistamines for patients with difficult-to-treat chronic spontaneous urticaria: A randomized, controlled trial.
    J Am Acad Dermatol. 2020;82:240-243.
    PubMed    


  129. WALDMAN RA, DeWane ME, Sloan B, Grant-Kels JM, et al
    Characterizing dupilumab facial redness: A multi-institution retrospective medical record review.
    J Am Acad Dermatol. 2020;82:230-232.
    PubMed    


  130. ADAMS L, Creamer D
    Controlling oral hemorrhages in Steven-Johnson syndrome/toxic epidermal necrolysis.
    J Am Acad Dermatol. 2020;82:e3-e4.
    PubMed    


    December 2019
  131. UCHIDA H, Kamata M, Nagata M, Fukaya S, et al
    Conjunctivitis in patients with atopic dermatitis treated with dupilumab is associated with higher baseline serum levels of IgE and TARC but not clinical severity in a real-world setting.
    J Am Acad Dermatol. 2019 Dec 26. pii: S0190-9622(19)33316.
    PubMed     Abstract available


  132. KOUROSH AS, Schneider L, Hawryluk EB, Tong L, et al
    Combining Teledermatology with Non-Physician Members of the Healthcare Team to Address Access and Compliance Barriers in Pediatric Atopic Dermatitis: A Needs Assessment.
    J Am Acad Dermatol. 2019 Dec 12. pii: S0190-9622(19)33255.
    PubMed    


  133. SILVERBERG JI, Lai JS, Vakharia PP, Patel K, et al
    Measurement properties of the Patient-Reported Outcomes Measurement Information System Itch Questionnaire(R) (PIQ) Item Banks in adults with atopic dermatitis.
    J Am Acad Dermatol. 2019 Dec 5. pii: S0190-9622(19)33149.
    PubMed     Abstract available


    November 2019
  134. TRAN JM, Reeder MJ
    When the Treatment is the Culprit: Prevalence of Allergens in Prescription Topical Steroids and Immunomodulators.
    J Am Acad Dermatol. 2019 Nov 15. pii: S0190-9622(19)33110.
    PubMed    


  135. NARDIN C, Jeand'heur A, Bouiller K, Valnet-Rabier MB, et al
    Vitiligo under anti-PD1 therapy is associated with increased survival in melanoma patients.
    J Am Acad Dermatol. 2019 Nov 14. pii: S0190-9622(19)33107.
    PubMed    


  136. PODDIGHE D
    The prevalence of chronic spontaneous urticaria (CSU) in the pediatric population.
    J Am Acad Dermatol. 2019;81:e149.
    PubMed    


    October 2019
  137. PAVEL AB, Zhou L, Diaz A, Ungar B, et al
    The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature.
    J Am Acad Dermatol. 2019 Oct 24. pii: S0190-9622(19)32961.
    PubMed     Abstract available


  138. WAN J, Takeshita J, Shin DB, Gelfand JM, et al
    Mental health impairment among children with atopic dermatitis: a U.S. population-based cross-sectional study of the 2013-2017 National Health Interview Survey.
    J Am Acad Dermatol. 2019 Oct 15. pii: S0190-9622(19)32902.
    PubMed     Abstract available


  139. IGELMAN S, Kurta AO, Sheikh U, McWilliams A, et al
    Off-label Use of Dupilumab for Pediatric Patients with Atopic Dermatitis: A Multicenter Retrospective Review.
    J Am Acad Dermatol. 2019 Oct 10. pii: S0190-9622(19)32890.
    PubMed     Abstract available


  140. WARSHAW EM, Schlarbaum JP, Taylor JS, Silverberg JI, et al
    Allergic Reactions to Tattoos: Retrospective Analysis of North American Contact Dermatitis Group Data 2001-2016.
    J Am Acad Dermatol. 2019 Oct 8. pii: S0190-9622(19)32828.
    PubMed    


  141. BOUTHILLETTE M, Beccati D, Akthakul A, Ramadurai N, et al
    A crosslinked polymer skin barrier film for moderate to severe atopic dermatitis: A pilot study in adults.
    J Am Acad Dermatol. 2019 Oct 4. pii: S0190-9622(19)32822.
    PubMed     Abstract available


  142. YEW YW, Silverberg JI
    Limitations of generalizability and reproducibility of systematic reviews in dermatology.
    J Am Acad Dermatol. 2019;81:1018-1019.
    PubMed    


    September 2019
  143. RAFFI J, Suresh R, Botto N, Murase JE, et al
    The impact of dupilumab on patch testing and the prevalence of co-morbid ACD in recalcitrant atopic dermatitis: a retrospective chart review.
    J Am Acad Dermatol. 2019 Sep 25. pii: S0190-9622(19)32772.
    PubMed     Abstract available


  144. GUZMAN AK, Zhang M, Kwatra SG, Kaffenberger BH, et al
    Predictors of 30-day Readmission in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective, Cross-sectional Database Study.
    J Am Acad Dermatol. 2019 Sep 19. pii: S0190-9622(19)32754.
    PubMed     Abstract available


  145. WOO TE, Sibley CD
    The emerging utility of the cutaneous microbiome in the treatment of acne and atopic dermatitis.
    J Am Acad Dermatol. 2019 Sep 6. pii: S0190-9622(19)32686.
    PubMed     Abstract available


  146. HEYMANN WR
    Predicting sepsis in Stevens-Johnson syndrome-toxic epidermal necrolysis: Should dermatologists be pro-procalcitonin?
    J Am Acad Dermatol. 2019;81:684-685.
    PubMed    


  147. ZOGHAIB S, Kechichian E, Souaid K, Soutou B, et al
    Triggers, clinical manifestations, and management of pediatric erythema multiforme: A systematic review.
    J Am Acad Dermatol. 2019;81:813-822.
    PubMed     Abstract available


  148. KOH HK, Chai ZT, Tay HW, Fook-Chong S, et al
    Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cohort study of 176 patients.
    J Am Acad Dermatol. 2019;81:686-693.
    PubMed     Abstract available


  149. WEINKLE A, Pettit C, Jani A, Keller J, et al
    Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation-A retrospective chart review.
    J Am Acad Dermatol. 2019;81:749-757.
    PubMed     Abstract available


  150. GONZALEZ CD, Hansen C, Clarke JT
    Adverse cutaneous drug reactions with antimalarials in cutaneous lupus and dermatomyositis: A retrospective cohort study.
    J Am Acad Dermatol. 2019;81:859-860.
    PubMed    


    August 2019
  151. SCHMIDT SAJ, Olsen M, Schmidt M, Vestergaard C, et al
    Atopic dermatitis and risk of atrial fibrillation or flutter: a 35-year follow-up study.
    J Am Acad Dermatol. 2019 Aug 20. pii: S0190-9622(19)32614.
    PubMed     Abstract available


  152. LI K, Mu Z, Wen G, Zhao Y, et al
    Increased Treg cells and eosinophils characterize atopic dermatitis-like graft-versus-host disease compared to lichen planus-like graft-versus host disease.
    J Am Acad Dermatol. 2019 Aug 9. pii: S0190-9622(19)32547.
    PubMed     Abstract available


  153. DRUCKER AM, Qureshi AA, Thompson JM, Li T, et al
    Gluten intake and risk of psoriasis, psoriatic arthritis and atopic dermatitis among US women.
    J Am Acad Dermatol. 2019 Aug 9. pii: S0190-9622(19)32549.
    PubMed     Abstract available


  154. PALLER AS, Siegfried EC, Vekeman F, Gadkari A, et al
    Treatment Patterns of Pediatric Patients with Atopic Dermatitis: A Claims Data Analysis.
    J Am Acad Dermatol. 2019 Aug 7. pii: S0190-9622(19)32500.
    PubMed     Abstract available


  155. MOSTOW E
    A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis.
    J Am Acad Dermatol. 2019 Aug 5. pii: S0190-9622(19)32484.
    PubMed    


  156. LECADET A, Woerther PL, Hua C, Colin A, et al
    Incidence of bloodstream infections and predictive value of qualitative and quantitative skin cultures of patients with overlap syndrome or toxic epidermal necrolysis: A retrospective observational cohort study of 98 cases.
    J Am Acad Dermatol. 2019;81:342-347.
    PubMed     Abstract available


  157. GUICCIARDI F, Atzori L, Marzano AV, Tavecchio S, et al
    Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study.
    J Am Acad Dermatol. 2019;81:403-411.
    PubMed     Abstract available


    July 2019
  158. DELEURAN M, Thaci D, Beck LA, de Bruin-Weller M, et al
    Dupilumab shows long-term safety and efficacy in moderate-to-severe atopic dermatitis patients enrolled in a phase 3 open-label extension study.
    J Am Acad Dermatol. 2019 Jul 30. pii: S0190-9622(19)32465.
    PubMed     Abstract available


  159. WALDMAN RA, DeWane ME, Sloan SB, King B, et al
    Dupilumab Ocular Surface Disease Occurs Predominantly in Patients receiving Dupilumab for Atopic Dermatitis: A Multi-institution Retrospective Chart Review.
    J Am Acad Dermatol. 2019 Jul 17. pii: S0190-9622(19)32391.
    PubMed    


  160. WERTENTEIL S, Strunk A, Garg A
    Prevalence estimates for chronic urticaria in the United States: A sex- and age-adjusted population analysis.
    J Am Acad Dermatol. 2019;81:152-156.
    PubMed     Abstract available


  161. ROSMAN Y, Hershko AY, Meir-Shafrir K, Kedem R, et al
    Characterization of chronic urticaria and associated conditions in a large population of adolescents.
    J Am Acad Dermatol. 2019;81:129-135.
    PubMed     Abstract available


    June 2019
  162. LEE HH, Patel KR, Rastogi S, Singam V, et al
    Placebo-responses in randomized controlled trials for systemic therapy in atopic dermatitis: a systematic review and meta-analysis.
    J Am Acad Dermatol. 2019 Jun 13. pii: S0190-9622(19)30970.
    PubMed     Abstract available


  163. EGEBERG A, Thyssen JP
    Factors associated with patient-reported importance of skin clearance among adults with psoriasis and atopic dermatitis.
    J Am Acad Dermatol. 2019 Jun 13. pii: S0190-9622(19)30981.
    PubMed     Abstract available


  164. STROWD LC
    Reply to: "Comment on 'Abnormal erythrocyte morphology in drug reaction with eosinophilia and systemic symptoms'".
    J Am Acad Dermatol. 2019;80:e183.
    PubMed    


  165. CHO YT, Chu CY
    Comment on "Abnormal erythrocyte morphology in drug reaction with eosinophilia and systemic symptoms".
    J Am Acad Dermatol. 2019;80:e181.
    PubMed    


  166. WARSHAW EM, Zhang AJ, Belsito DV, Fowler JF Jr, et al
    Patients with negative patch tests: Retrospective analysis of North American Contact Dermatitis Group (NACDG) data 2001-2016.
    J Am Acad Dermatol. 2019;80:1618-1629.
    PubMed     Abstract available


  167. WANG RF, Li D, Kuehn GJ, Andritsos LA, et al
    Antibiotic exposure is associated with cutaneous adverse events in hairy cell leukemia patients treated with purine analogues.
    J Am Acad Dermatol. 2019;80:1762-1764.
    PubMed    


  168. COMPANY-QUIROGA J, Alique-Garcia S, Esteban-Garrido E, Rojas-Farias FE, et al
    Skin stripping technique: A diagnostic clue for fiberglass dermatitis.
    J Am Acad Dermatol. 2019;80:e141-e142.
    PubMed    


    May 2019
  169. SCHNEEWEISS MC, Perez-Chada L, Merola JF
    Comparative Safety of Systemic Immuno-modulatory Medications in Adults with Atopic Dermatitis.
    J Am Acad Dermatol. 2019 May 31. pii: S0190-9622(19)30877.
    PubMed     Abstract available


  170. HUA T, Silverberg JI
    Atopic dermatitis is associated with increased hospitalization in United States children.
    J Am Acad Dermatol. 2019 May 11. pii: S0190-9622(19)30782.
    PubMed    


  171. WAN J, Mitra N, Hoffstad OJ, Yan AC, et al
    Longitudinal atopic dermatitis control and persistence vary with timing of disease onset in children: a cohort study.
    J Am Acad Dermatol. 2019 May 11. pii: S0190-9622(19)30778.
    PubMed     Abstract available


  172. CHABY G, Ingen-Housz-Oro S, De Prost N, Wolkenstein P, et al
    Idiopathic Stevens-Johnson syndrome and toxic epidermal necrolysis: Prevalence and patients' characteristics.
    J Am Acad Dermatol. 2019;80:1453-1455.
    PubMed    


  173. PAO-LING LIN C, Gordon S, Her MJ, Rosmarin D, et al
    A retrospective study: Application site pain with the use of crisaborole, a topical phosphodiesterase 4 inhibitor.
    J Am Acad Dermatol. 2019;80:1451-1453.
    PubMed    


  174. LAKE E
    JAAD Game Changers: Acquired cold urticaria: Clinical features, particular phenotypes, and disease course in a tertiary care center cohort.
    J Am Acad Dermatol. 2019;80:1198.
    PubMed    


    April 2019
  175. BRUNNER PM, He H, Pavel AB, Czarnowicki T, et al
    The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult, longstanding disease.
    J Am Acad Dermatol. 2019 Apr 19. pii: S0190-9622(19)30628.
    PubMed     Abstract available


  176. DORRELL DN, Whitaker LF, Anderson KL, Strowd LC, et al
    Abnormal erythrocyte morphology in drug reaction with eosinophilia and systemic symptoms.
    J Am Acad Dermatol. 2019;80:1159-1160.
    PubMed    


  177. COLEMAN E, Ko C, Dai F, Tomayko MM, et al
    Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management.
    J Am Acad Dermatol. 2019;80:990-997.
    PubMed     Abstract available


    March 2019
  178. ECKERT L, Gupta S, Gadkari A, Mahajan P, et al
    Burden of illness in adults with atopic dermatitis (AD): analysis of National Health and Wellness Survey data from France, Germany, Italy, Spain and the U.K.
    J Am Acad Dermatol. 2019 Mar 21. pii: S0190-9622(19)30453.
    PubMed     Abstract available


  179. ADLER BL, DeLeo VA
    Allergenic ingredients in commercial topical cannabinoid preparations.
    J Am Acad Dermatol. 2019 Mar 15. pii: S0190-9622(19)30429.
    PubMed    


  180. STOUT M, Silverberg JI
    Variable impact of dupilumab on patch testing results and allergic contact dermatitis in adults with atopic dermatitis.
    J Am Acad Dermatol. 2019 Mar 15. pii: S0190-9622(19)30434.
    PubMed     Abstract available


  181. SINGH P, Silverberg JI
    Outpatient utilization patterns for atopic dermatitis in the United States.
    J Am Acad Dermatol. 2019 Mar 15. pii: S0190-9622(19)30435.
    PubMed     Abstract available


  182. MORI S, Hickey A, Dusza SW, Lacouture ME, et al
    Markers of systemic involvement and death in hospitalized cancer patients with severe cutaneous adverse reactions.
    J Am Acad Dermatol. 2019;80:608-616.
    PubMed     Abstract available


  183. WARSHAW EM, Zhang AJ, DeKoven JG, Maibach HI, et al
    Epidemiology of nickel sensitivity: Retrospective cross-sectional analysis of North American Contact Dermatitis Group data 1994-2014.
    J Am Acad Dermatol. 2019;80:701-713.
    PubMed     Abstract available


  184. GOTTLIEB A, Salame N, Armstrong AW, Merola JF, et al
    A provider global assessment quality measure for clinical practice for inflammatory skin disorders.
    J Am Acad Dermatol. 2019;80:823-828.
    PubMed     Abstract available


  185. LIU Z, Chen L, Zhang C, Xiang LF, et al
    Circulating bullous pemphigoid 180 autoantibody can be detected in a wide spectrum of patients with other dermatologic conditions: A cross-sectional study.
    J Am Acad Dermatol. 2019;80:774-775.
    PubMed    


    February 2019
  186. FAIZ S, Giovannelli J, Podevin C, Jachiet M, et al
    Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort.
    J Am Acad Dermatol. 2019 Feb 27. pii: S0190-9622(19)30345.
    PubMed     Abstract available


  187. BRIDGMAN AC, Qureshi A, Li T, Tabung FK, et al
    Inflammatory dietary pattern and incident psoriasis, psoriatic arthritis, and atopic dermatitis in women: a cohort study.
    J Am Acad Dermatol. 2019 Feb 21. pii: S0190-9622(19)30329.
    PubMed     Abstract available


  188. MADIGAN LM, Fox LP
    Vancomycin-associated Drug-Induced Hypersensitivity Syndrome (DIHS).
    J Am Acad Dermatol. 2019 Feb 6. pii: S0190-9622(19)30197.
    PubMed     Abstract available


  189. LISZEWSKI W, Warshaw EM
    Pigments in American Tattoo Inks and their Propensity to Elicit Allergic Contact Dermatitis.
    J Am Acad Dermatol. 2019 Feb 4. pii: S0190-9622(19)30189.
    PubMed     Abstract available


    January 2019
  190. HUGHES ME, Aralis H, Bruhn KW, Cotliar J, et al
    "A Reliability Study Using Network-Oriented Research Assistant (NORA((R))) to Evaluate the Use of Digital Photographs in the Assessment of Atopic Dermatitis".
    J Am Acad Dermatol. 2019 Jan 28. pii: S0190-9622(19)30150.
    PubMed    


  191. CHIPALKATTI N, Lee N, Zancanaro P, Dumont N, et al
    A Retrospective Review of Dupilumab for Atopic Dermatitis Patients with Allergic Contact Dermatitis.
    J Am Acad Dermatol. 2019 Jan 7. pii: S0190-9622(19)30011.
    PubMed    


  192. PEPPERS J, Paller AS, Maeda-Chubachi T, Wu S, et al
    A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis.
    J Am Acad Dermatol. 2019;80:89-98.
    PubMed     Abstract available


    December 2018
  193. SIMPSON EL, Parnes JR, She D, Crouch S, et al
    Tezepelumab, an anti-TSLP monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial.
    J Am Acad Dermatol. 2018 Dec 11. pii: S0190-9622(18)33050.
    PubMed     Abstract available


  194. SIEGEL J, Totonchy M, Damsky W, Berk-Krauss J, et al
    Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy.
    J Am Acad Dermatol. 2018;79:1081-1088.
    PubMed     Abstract available


  195. KIM WB, Worley B, Holmes J, Phillips EJ, et al
    Minimal clinically important differences for measures of treatment efficacy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    J Am Acad Dermatol. 2018;79:1150-1152.
    PubMed    


  196. ROSEN JD, Fostini AC, Chan YH, Nattkemper LA, et al
    Cross-sectional study of clinical distinctions between neuropathic and inflammatory pruritus.
    J Am Acad Dermatol. 2018;79:1143-1144.
    PubMed    


  197. MIN LEE CK, Li S, Tran DC, Zhu GA, et al
    Characterization of dermatitis after PD-1/PD-L1 inhibitor therapy and association with multiple oncologic outcomes: A retrospective case-control study.
    J Am Acad Dermatol. 2018;79:1047-1052.
    PubMed     Abstract available


  198. NELSON CA, Stephen S, Ashchyan HJ, James WD, et al
    Neutrophilic dermatoses: Pathogenesis, Sweet syndrome, neutrophilic eccrine hidradenitis, and Behcet disease.
    J Am Acad Dermatol. 2018;79:987-1006.
    PubMed     Abstract available


    November 2018
  199. SERRANO L, Patel KR, Silverberg JI
    Association between atopic dermatitis and extra-cutaneous bacterial and mycobacterial infections: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2018 Nov 21. pii: S0190-9622(18)32954.
    PubMed     Abstract available


  200. COUTEAU C, Coiffard LJM
    Are alkyl glucosides really allergens?
    J Am Acad Dermatol. 2018 Nov 14. pii: S0190-9622(18)32895.
    PubMed    


  201. HEYMANN WR
    "Tar Smarts" May Have a New Meaning for Atopic Dermatitis and Psoriasis.
    J Am Acad Dermatol. 2018 Nov 2. pii: S0190-9622(18)32828.
    PubMed    


    October 2018
  202. LAKE E
    Game Changer: Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD).
    J Am Acad Dermatol. 2018 Oct 30. pii: S0190-9622(18)32822.
    PubMed    


  203. PATEL KR, Immaneni S, Singam V, Rastogi S, et al
    Association between atopic dermatitis, depression and suicidal ideation: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2018 Oct 23. pii: S0190-9622(18)32758.
    PubMed     Abstract available


  204. SEGER EW, Wechter T, Strowd L, Feldman SR, et al
    Relative efficacy of systemic treatments for atopic dermatitis.
    J Am Acad Dermatol. 2018 Oct 5. pii: S0190-9622(18)32669.
    PubMed     Abstract available


  205. FLEISCHER AB JR
    Guideline-Based Medicine Grading based upon the Guidelines of Care for Ambulatory Atopic Dermatitis Treatment in the United States.
    J Am Acad Dermatol. 2018 Oct 1. pii: S0190-9622(18)32636.
    PubMed     Abstract available


  206. NARLA S, Silverberg JI
    Association between atopic dermatitis and autoimmune disorders in US adults and children: A cross-sectional study.
    J Am Acad Dermatol. 2018 Oct 1. pii: S0190-9622(18)32635.
    PubMed     Abstract available


  207. YEW YW, Thyssen JP, Silverberg JI
    A systematic review and meta-analysis of the regional and age-related differences of atopic dermatitis clinical characteristics.
    J Am Acad Dermatol. 2018 Oct 1. pii: S0190-9622(18)32645.
    PubMed     Abstract available


  208. LEE HY
    Wound management strategies in Stevens-Johnson syndrome/toxic epidermal necrolysis: An unmet need.
    J Am Acad Dermatol. 2018;79:e87-e88.
    PubMed    


  209. CASTILLO B, Vera N, Ortega-Loayza AG, Seminario-Vidal L, et al
    Reply to: "Wound management strategies in Stevens-Johnson syndrome/toxic epidermal necrolysis: An unmet need".
    J Am Acad Dermatol. 2018;79:e89.
    PubMed    


  210. ANTIA C, Baquerizo K, Korman A, Alikhan A, et al
    Urticaria: A comprehensive review: Treatment of chronic urticaria, special populations, and disease outcomes.
    J Am Acad Dermatol. 2018;79:617-633.
    PubMed     Abstract available


  211. ANTIA C, Baquerizo K, Korman A, Bernstein JA, et al
    Urticaria: A comprehensive review: Epidemiology, diagnosis, and work-up.
    J Am Acad Dermatol. 2018;79:599-614.
    PubMed     Abstract available


  212. WARSHAW EM, Aschenbeck KA, DeKoven JG, Maibach HI, et al
    Epidemiology of pediatric nickel sensitivity: Retrospective review of North American Contact Dermatitis Group (NACDG) data 1994-2014.
    J Am Acad Dermatol. 2018;79:664-671.
    PubMed     Abstract available


  213. BJERRE RD, Ulrich NH, Linneberg A, Duus Johansen J, et al
    Adverse reactions to tattoos in the general population of Denmark.
    J Am Acad Dermatol. 2018;79:770-772.
    PubMed    


  214. CASTILLO B, Vera N, Ortega-Loayza AG, Seminario-Vidal L, et al
    Wound care for Stevens-Johnson syndrome and toxic epidermal necrolysis.
    J Am Acad Dermatol. 2018;79:764-767.
    PubMed    


    September 2018
  215. MIZUKAWA Y, Hirahara K, Kano Y, Shiohara T, et al
    Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease.
    J Am Acad Dermatol. 2018 Sep 18. pii: S0190-9622(18)32585.
    PubMed     Abstract available


  216. RONNSTAD ATM, Halling-Overgaard AS, Hamann CR, Skov L, et al
    Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2018;79:448-456.
    PubMed     Abstract available


  217. STEINKE S, Zeidler C, Riepe C, Bruland P, et al
    Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial.
    J Am Acad Dermatol. 2018;79:457-463.
    PubMed     Abstract available


  218. HOSKING AM, Juhasz M, Mesinkovska NA
    Topical Janus kinase inhibitors: A review of applications in dermatology.
    J Am Acad Dermatol. 2018;79:535-544.
    PubMed     Abstract available


  219. RZEPECKI AK, Cheng H, McLellan BN
    Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy.
    J Am Acad Dermatol. 2018;79:545-555.
    PubMed     Abstract available


  220. KUMARAN MS, Razmi T M, Vinay K, Parsad D, et al
    Clinical, dermoscopic, and trichoscopic analysis of frontal fibrosing alopecia associated with acquired dermal macular hyperpigmentation: A cross sectional observational case-control study.
    J Am Acad Dermatol. 2018;79:588-591.
    PubMed    


  221. TSAI TY, Huang YC
    Vitamin D deficiency in patients with chronic and acute urticaria: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2018;79:573-575.
    PubMed    


  222. MAXIM E, Aksut C, Tsoi D, Dellavalle R, et al
    Global burden of urticaria: Insights from the 2016 Global Burden of Disease Study.
    J Am Acad Dermatol. 2018;79:567-569.
    PubMed    


    August 2018
  223. MACHLER BC, Sung CT, Darwin E, Jacob SE, et al
    Dupilumab use in allergic contact dermatitis.
    J Am Acad Dermatol. 2018 Aug 6. pii: S0190-9622(18)32345.
    PubMed    


  224. BLAUVELT A, Simpson EL, Tyring SK, Purcell LA, et al
    Dupilumab does not affect correlates of vaccine-induced immunity: a randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis.
    J Am Acad Dermatol. 2018 Aug 6. pii: S0190-9622(18)32351.
    PubMed     Abstract available


  225. BREGEON B, Bernier C, Josselin N, Peuvrel L, et al
    DRESS syndrome induced by the combination of vemurafenib and cobimetinib in melanoma: a series of 11 cases.
    J Am Acad Dermatol. 2018 Aug 3. pii: S0190-9622(18)32329.
    PubMed    


  226. SIMPSON EL, Reynolds NJ, Flohr C, Paller AS, et al
    Response to "Comment on: 'When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council'".
    J Am Acad Dermatol. 2018;79:e25-e26.
    PubMed    


  227. DAUNTON A, Goulding JMR
    Comment on: "When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council".
    J Am Acad Dermatol. 2018;79:e23-e24.
    PubMed    


    July 2018
  228. RASTOGI S, Patel KR, Singam V, Silverberg JI, et al
    Allergic Contact Dermatitis To Personal Care Products And Topical Medications In Adults With Atopic Dermatitis.
    J Am Acad Dermatol. 2018 Jul 24. pii: S0190-9622(18)32316.
    PubMed     Abstract available


  229. VASHI NA, Patzelt N, Wirya S, Maymone MBC, et al
    Dermatoses caused by cultural practices: Cosmetic cultural practices.
    J Am Acad Dermatol. 2018;79:19-30.
    PubMed     Abstract available


    June 2018
  230. ZIRWAS M, Dobkin H
    2-methoxymethyl-para-phenylenediamine containing hair dye as a less allergenic alternative for para-phenylenediamine allergic individuals.
    J Am Acad Dermatol. 2018 Jun 16. pii: S0190-9622(18)32141.
    PubMed    


  231. LEE HH, Patel KR, Singam V, Rastogi S, et al
    A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis.
    J Am Acad Dermatol. 2018 Jun 1. pii: S0190-9622(18)32046.
    PubMed     Abstract available


  232. PHILLIPS GS, Freites-Martinez A, Hsu M, Skripnik Lucas A, et al
    Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients.
    J Am Acad Dermatol. 2018;78:1102-1109.
    PubMed     Abstract available


  233. NETTIS E, Di Leo E, Foti C, Cegolon L, et al
    Efficacy and rapid activity of omalizumab retreatment in chronic spontaneous urticaria.
    J Am Acad Dermatol. 2018;78:1211-1213.
    PubMed    


    May 2018
  234. MCKENZIE C, Silverberg JI
    Association of family structure with atopic dermatitis in United States children.
    J Am Acad Dermatol. 2018 May 31. pii: S0190-9622(18)30835.
    PubMed     Abstract available


  235. KWA L, Silverberg JI
    Financial burden of emergency department visits for atopic dermatitis in the United States.
    J Am Acad Dermatol. 2018 May 22. pii: S0190-9622(18)30821.
    PubMed     Abstract available


  236. SHAHEEN MS, Silverberg JI
    Atopic dermatitis is associated with osteoporosis and osteopenia in older adults.
    J Am Acad Dermatol. 2018 May 22. pii: S0190-9622(18)30822.
    PubMed    


    April 2018
  237. HEYMANN WR
    Keeping an eye on atopic dermatitis.
    J Am Acad Dermatol. 2018 Apr 19. pii: S0190-9622(18)30628.
    PubMed    


  238. FISHBEIN AB, Lin B, Beaumont J, Paller AS, et al
    Nocturnal Movements in Children with Atopic Dermatitis have a Timing Pattern: A Case Control Study.
    J Am Acad Dermatol. 2018 Apr 16. pii: S0190-9622(18)30564.
    PubMed    


  239. CASALE TB, Win PH, Bernstein JA, Rosen K, et al
    Omalizumab response in patients with chronic idiopathic urticaria: Insights from the XTEND-CIU study.
    J Am Acad Dermatol. 2018;78:793-795.
    PubMed    


    March 2018
  240. FREEMYER B, Drozd B, Suarez A
    A cross-sectional study of YouTube videos about atopic dermatitis.
    J Am Acad Dermatol. 2018;78:612-613.
    PubMed    


  241. GOODERHAM MJ, Hong HC, Eshtiaghi P, Papp KA, et al
    Dupilumab: A review of its use in the treatment of atopic dermatitis.
    J Am Acad Dermatol. 2018;78.
    PubMed     Abstract available


  242. PALLER AS, Czarnowicki T, Renert-Yuval Y, Holland K, et al
    The spectrum of manifestations in desmoplakin gene (DSP) spectrin repeat 6 domain mutations: Immunophenotyping and response to ustekinumab.
    J Am Acad Dermatol. 2018;78:498-505.
    PubMed     Abstract available


  243. ZEBDA R, Paller AS
    Phosphodiesterase 4 inhibitors.
    J Am Acad Dermatol. 2018;78.
    PubMed     Abstract available


    February 2018
  244. JEON HS, Choi M, Byun SJ, Suh LH, et al
    Atopic Dermatitis is Not a Risk Factor for Keratoconus: A Population-based Cohort Study.
    J Am Acad Dermatol. 2018 Feb 22. pii: S0190-9622(18)30324.
    PubMed    


  245. GUTTMAN-YASSKY E, Silverberg JI, Nemoto O, Forman SB, et al
    Baricitinib in adult patients with moderate-to-severe atopic dermatitis: a phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study.
    J Am Acad Dermatol. 2018 Feb 1. pii: S0190-9622(18)30129.
    PubMed     Abstract available


  246. ZINN Z, Gayam S, Chelliah MP, Honari G, et al
    Patch testing for nonimmediate cutaneous adverse drug reactions.
    J Am Acad Dermatol. 2018;78:421-423.
    PubMed    


  247. BOGGIO F, Lora V, Cota C, Pereira A, et al
    Cutaneous hemophagocytosis: Clinicopathologic features of 21 cases.
    J Am Acad Dermatol. 2018;78:377-382.
    PubMed     Abstract available


    January 2018
  248. SIMPSON EL, Flohr C, Eichenfield LF, Bieber T, et al
    Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE).
    J Am Acad Dermatol. 2018 Jan 15. pii: S0190-9622(18)30102.
    PubMed     Abstract available


  249. GUTTMAN-YASSKY E, Brunner PM, Neumann AU, Khattri S, et al
    Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial.
    J Am Acad Dermatol. 2018 Jan 15. pii: S0190-9622(18)30101.
    PubMed     Abstract available


  250. HE A, Feldman SR, Fleischer AB Jr.
    An assessment of the use of antihistamines in the management of atopic dermatitis.
    J Am Acad Dermatol. 2018 Jan 6. pii: S0190-9622(18)30020.
    PubMed     Abstract available


  251. ST JOHN J, Vedak P, Garza-Mayers AC, Hoang MP, et al
    Location of skin lesions in Henoch-Schonlein purpura and its association with significant renal involvement.
    J Am Acad Dermatol. 2018;78:115-120.
    PubMed     Abstract available


  252. MITTAL L, Zhang L, Feng R, Werth VP, et al
    Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study.
    J Am Acad Dermatol. 2018;78:100-106.
    PubMed     Abstract available


    December 2017
  253. BONCHAK JG, Swerlick RA
    Emerging Therapies for Atopic Dermatitis: TRPV1 Antagonists.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32825.
    PubMed     Abstract available


  254. YANES DA, Mosser-Goldfarb JL
    Emerging Therapies for Atopic Dermatitis: The Prostaglandin/Leukotriene Pathway.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32822.
    PubMed     Abstract available


  255. HAMANN CR, Thyssen JP
    Monoclonal Antibodies Against IL-13 and IL-31RA in Development for Atopic Dermatitis.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32819.
    PubMed     Abstract available


  256. VAKHARIA PP, Silverberg JI
    New Therapies for Atopic Dermatitis: Additional Treatment Classes.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32826.
    PubMed     Abstract available


  257. TIDWELL WJ, Fowler JF Jr
    T-Cell Inhibitors for Atopic Dermatitis.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32821.
    PubMed     Abstract available


  258. COTTER DG, Schairer D, Eichenfield L
    Emerging Therapies for Atopic Dermatitis: Jak Inhibitors.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32820.
    PubMed     Abstract available


  259. ZIRWAS MJ
    The Future is Finally Here: Advances in the Treatment of Atopic Dermatitis.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32827.
    PubMed    


  260. FAINA V, Paolino G, Bavastrelli M, Calvieri S, et al
    Classification of cutaneous manifestations in patients with non-celiac gluten sensitivity (NCGS) and wheat allergy (WA).
    J Am Acad Dermatol. 2017 Dec 13. pii: S0190-9622(17)32811.
    PubMed    


    November 2017
  261. THYSSEN JP, Skov L, Egeberg A
    Cause specific mortality in adults with atopic dermatitis.
    J Am Acad Dermatol. 2017 Nov 1. pii: S0190-9622(17)32590.
    PubMed     Abstract available


  262. RICKSTREW J, Wang T, Liu D, Rajpara A, et al
    Mitigation or prevention of mild hair dye contact dermatitis after pretreatment with clobetasol foam.
    J Am Acad Dermatol. 2017;77:e129.
    PubMed    


  263. LAM BD, Miller MM, Sutton AV, Peng D, et al
    Vancomycin and DRESS: A retrospective chart review of 32 cases in Los Angeles, California.
    J Am Acad Dermatol. 2017;77:973-975.
    PubMed    


    October 2017
  264. FISHBEIN AB, Mueller K, Kruse L, Boor P, et al
    Sleep disturbance in children with moderate/severe atopic dermatitis: A case-control study.
    J Am Acad Dermatol. 2017 Oct 28. pii: S0190-9622(17)32306.
    PubMed     Abstract available


  265. BOOZALIS E, Patel S
    "Allergen of the Year" alkyl glucoside is an ingredient in top-selling sunscreens and facial moisturizers.
    J Am Acad Dermatol. 2017 Oct 14. pii: S0190-9622(17)32539.
    PubMed    


  266. YU S, Drucker AM, Lebwohl M, Silverberg JI, et al
    A systematic review of safety and efficacy of systemic corticosteroids in atopic dermatitis.
    J Am Acad Dermatol. 2017 Oct 12. pii: S0190-9622(17)32533.
    PubMed     Abstract available


  267. ECKERT L, Gupta S, Amand C, Gadkari A, et al
    The burden of atopic dermatitis in US adults: Health care resource utilization data from the 2013 National Health and Wellness Survey.
    J Am Acad Dermatol. 2017 Oct 7. pii: S0190-9622(17)32181.
    PubMed     Abstract available


  268. FLEMING P, Drucker AM
    Risk of Infection in Patients with Atopic Dermatitis Treated with Dupilumab: A Meta-Analysis of Randomized Controlled Trials.
    J Am Acad Dermatol. 2017 Oct 4. pii: S0190-9622(17)32457.
    PubMed     Abstract available


  269. KONG BY, Immaneni S, Paller AS, Xu S, et al
    Potential impact of biologics and emerging therapies for psoriasis and atopic dermatitis on future fertility: Reassurance to patients but more data are needed.
    J Am Acad Dermatol. 2017;77:758-763.
    PubMed    


  270. SILVERBERG JI, Hsu DY, Brieva J, Silverberg NB, et al
    Reply to: "Prognosis and management of Stevens-Johnson syndrome and toxic epidermal necrolysis".
    J Am Acad Dermatol. 2017;77:e119.
    PubMed    


  271. SCHNEIDER JA, Cohen PR
    Prognosis and management of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    J Am Acad Dermatol. 2017;77:e117.
    PubMed    


  272. HSU CY, Lee WR, Shih YH
    Recalcitrant chronic leg ulcer: An indication for patch testing for hydrocolloid dressing.
    J Am Acad Dermatol. 2017;77:e97-e98.
    PubMed    


  273. CHANSKY PB, Wanat K, Pappas-Taffer L, Rosenbach M, et al
    A cross-sectional survey of voriconazole prescribers: Assessing current practice and knowledge of cutaneous side effects.
    J Am Acad Dermatol. 2017;77:769-770.
    PubMed    


    September 2017
  274. BELUM VR, Marchetti MA, Dusza SW, Cercek A, et al
    A prospective, randomized, double-blinded, split-face/chest study of prophylactic topical dapsone 5% gel versus moisturizer for the prevention of cetuximab-induced acneiform rash.
    J Am Acad Dermatol. 2017;77:577-579.
    PubMed    


    July 2017
  275. OLIVER B, Free R, Aires D
    Preapplication of white petroleum jelly to adjacent skin to prevent aluminum chloride-induced irritant dermatitis.
    J Am Acad Dermatol. 2017;77:e7.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: